Prostate cancer in Australia

Publication

Release Date: 14 Nov 2013

Author: AIHW

Media release

AIHW

Australian Institute of Health and Welfare 2013. Prostate cancer in Australia. Cat. no. CAN 76. Canberra: AIHW.

APA

Australian Institute of Health and Welfare. (2013). Prostate cancer in Australia. Canberra: AIHW.

MLA

Australian Institute of Health and Welfare. Prostate cancer in Australia. AIHW, 2013.

Vancouver

Australian Institute of Health and Welfare. Prostate cancer in Australia. Canberra: AIHW; 2013.

Harvard

Australian Institute of Health and Welfare 2013, Prostate cancer in Australia, AIHW, Canberra.

PDF Report (1.8Mb)

Download report

View other formats

Enter the email address where you would like the PDF sent. This address will not be used for any other purpose.

This is the first comprehensive national report on prostate cancer in Australia. It presents an overview of the condition and analysis of key summary measures including incidence, mortality and survival.

ISSN: 1039-3307
ISBN: 978-1-74249-508-8
Cat. no: CAN 76
Pages: 71

Findings from this report:

Prostate cancer is the most commonly diagnosed cancer in Australia, with 21,808 new diagnoses in 2009
Around 9 in 10 males diagnosed with prostate cancer survive 5 years from diagnosis
Indigenous males were less likely to be diagnosed with, but similarly likely to die from, prostate cancer
Health-care expenditure on prostate cancer was estimated to increase 23% between 2004–05 and 2008–09, to $349 million

Preliminary material
- Title and verso page
- Contents
- Acknowledgments
- Abbreviations
- Symbols
- Summary
  - Prostate cancer is the leading cancer among males
  - Mortality is decreasing
  - Survival is high, and improving
  - Prostate cancer presents an economic burden
  - There are differences between population groups and internationally
Body section
- 1 Introduction
  - Overview
  - The prostate
  - Prostate cancer
  - Characteristics
  - Risk factors
- 2 Detection, diagnosis and management
  - Key findings
  - Detection and diagnosis
  - Prostate-specific antigen testing
  - Digital rectal examination
  - Biopsy of the prostate
  - Management and treatment
  - No initial treatment, active surveillance
  - Active treatment
  - Palliative care
- 3 Incidence
  - Key findings
  - Overview
  - Age comparison
  - Time trend
  - Projected incidence to 2020
- 4 Mortality
  - Key findings
  - Overview
  - Age comparison
  - Time trend
  - The influence of incidence on mortality
  - Projected mortality to 2020
- 5 Survival
  - Key findings
  - Overview
  - Age comparison
  - Time trend
- 6 Expenditure on prostate cancer
  - Key findings
  - Overview
  - Age comparison
  - Time trend
- 7 Population groups
  - Key findings
  - Overview
  - State and territory
  - Aboriginal and Torres Strait Islander status
  - Remoteness area
  - Socioeconomic disadvantage
  - Country of birth
- 8 International comparisons
  - Key findings
  - Overview
  - Incidence
  - Mortality
  - Mortality-to-incidence ratio
End matter
- Appendix 1 Technical information
  - Classifications
  - Health classifications
  - Area-based classifications
  - Data sources and limitations
  - AIHW data sources
  - External data sources
  - Data limitations
  - Statistical methods
  - Age-specific rates
  - Age-standardisation
  - Incidence
  - Prevalence
  - Risk to age 45, 55, 65, 75 or 85
  - Survival
  - Technical notes
  - Defining prostate cancer-related hospitalisations
  - Interpreting comparison data
- References
- List of tables
- List of figures
- List of boxes
- Related publications

Find reports & data by topic

Featured

Prostate cancer in Australia

Citation

AIHW

APA

MLA

Vancouver

Harvard

Table of contents

AIHW

Feedback